Phase III trial of doxorubicin administered via isolated hepatic infusion (Delcath system) compared with controls in patients with liver metastases from malignant melanoma.
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2012
At a glance
- Drugs Doxorubicin (Primary)
- Indications Cancer metastases; Malignant melanoma
- Focus Registrational; Therapeutic Use
- 23 Aug 2006 New trial record.